Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-17 · accession 0001209191-22-020337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-21 | 2022-03-17 | DTIL | Kelly John Alexander | CFO | P - Purchase | $3.08 | +16.7K | 36.2K | +85% | +$51.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | P | A | 16,677 | $3.08 | 36,189 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.05 to $3.09. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. |